Sofinnova Partners

#AI #Drug development #Sofinnova Partners

Ingenix raises €13m to scale AI drug development model 

AI company Ingenix has announced it has raised €13 million to scale its drug development model.  Ingenix says its Biological Reasoning Engine overcomes structural problems in AI drug development, integrating best-in-class models across modalities and biological scales.  The model was applied to a dual-payload ADC prioritisation… Read More

#News

#Artificial intelligence (AI) #Investment #Life sciences #NVIDIA #Sofinnova Partners #Start-ups

Collaboration to accelerate European life sciences startups

Sofinnova Partners, a European life sciences venture capital firm based in Paris, London, and Milan, has collaborated with NVIDIA to support its portfolio of life sciences startups. The collaboration delivers significant Graphics Processing Unit (GPU) credits to select Sofinnova portfolio companies, effectively giving access to the same computational… Read More

#Business & Investment #News #Start-up Zone